Become a Distributor
Mimetis is looking for distributors.
About Mimetis
Mimetis is a bone regenerative solutions manufacturer based in Barcelona (Spain). We manufacture the first biomimetic bone graft substitute used for regeneration in dental and orthopedic practice.
Our Products
MimetikOss Granules
In essence, our biomimetic synthetic bone graft is available in two forms. Firstly, MimetikOss Granules a practical, easy to use, and efficient bone graft solution. In short, MimetikOss Granules is available in small-sized granules for dental bone regeneration use. Additionally, MimetikOss Granules come in medium-sized granules, both of which come in 1 cc canisters.
MimetikOss 3D
In parallel, Mimetis also offers a fully personalized patient-specific biomimetic synthetic bone graft. Comparatively to the granules, MimetikOss 3D is not a sintered synthetic solution. Instead, it is manufactured at low temperatures, closer to the human body’s temperature. So the end product mimics the mineral phase of the human bone. As a result, the implanted bone graft is recognized as natural bone, facilitating angiogenesis, and osseointegration.
Our Certificates
The company complies with ISO 13485 and the European Medical Device Directive (MDD) 93/42 / EEC.
We are looking for distributors.!
Get in touch with our Chief Business Development Officer to become a distributor
Our Portfolio's Indications
MimetikOss Granules
In essence, our biomimetic synthetic bone graft is available in two forms. Firstly, MimetikOss Granules a practical, easy to use, and efficient bone graft solution. In short, MimetikOss Granules is available in small-sized granules for dental bone regeneration use. Additionally, MimetikOss Granules come in medium-sized granules, both of which come in 1 cc canisters.
MimetikOss 3D
In parallel, Mimetis also offers a fully personalized patient-specific biomimetic synthetic bone graft. Comparatively to the granules, MimetikOss 3D is not a sintered synthetic solution. Instead, it is manufactured at low temperatures, closer to the human body’s temperature. So the end product mimics the mineral phase of the human bone. As a result, the implanted bone graft is recognized as natural bone, facilitating angiogenesis, and osseointegration.
Scientific Evidence
